Company Directory / biotechnology
PrivateFor profitbiotechnologyUnited Kingdom
Karus is a pharmaceutical company focused on the design and development of molecular-targeted, small molecule drugs to treat cancer.
Size
11-50 people: larger than 33% of companies with a size listed
Age
21 years old.
Reach
No web traffic ranking listed.
BiotechnologyLife SciencePharmaceutical
Funding, as listed
$15M currency not stated
What the source datasets report. We have not watched these rounds ourselves.
Everything the source datasets list about Karus Therapeutics, field by field. Contact details are held but never shown.
The company
Where
Size and reach
Funding, as listed
About this record
Growth, as the source summarises it
Karus Therapeutics may be growing as it is mentioned in the context of a rapidly growing market for Epidermolysis Bullosa treatments, indicating a potentially expanding market presence. The company is also listed in a report on the global Histone Deacetylase (HDAC) Inhibitors market, suggesting active sales and market participation. Furthermore, Karus Therapeutics is included in discussions about the blepharitis pipeline industry, which is expected to witness significant growth from 2023 to 2029, implying that the company is involved in sectors that are experiencing an upward trend.
Summaries written by the source dataset, not by us, and not checked.
biotechnology in United Kingdom.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 372,993 companies in United Kingdom and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.